ENOV Enovis Corp Forecast, Technical & Fundamental Analysis
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy... Show more
ENOV is expected to report earnings to fall 6.66% to 84 cents per share on November 11
Q3'26
Est.
$0.84
Q2'26
Beat
by $0.05
Q1'26
Beat
by $0.08
Q4'25
Beat
by $0.13
Q3'25
Beat
by $0.10
The last earnings report on August 06 showed earnings per share of 89 cents, beating the estimate of 85 cents. With 266.17K shares outstanding, the current market capitalization sits at 1.40B.
A.I. Advisor
published General Information
General Information
a manufacturer of fluid handling and industrial positioning products
A.I.dvisor indicates that over the last year, ENOV has been loosely correlated with FELE. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ENOV jumps, then FELE could also see price increases.
ENOV in upward trend: price rose above 50-day moving average on July 06, 2026
ENOV moved above its 50-day moving average on July 06, 2026 date and that indicates a change from a downward trend to an upward trend. In of 37 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The 10-day moving average for ENOV crossed bullishly above the 50-day moving average on July 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ENOV advanced for three days, in of 266 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 192 cases where ENOV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The 10-day RSI Indicator for ENOV moved out of overbought territory on August 04, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 56 cases where ENOV's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on August 07, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ENOV as a result. In of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for ENOV turned negative on August 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ENOV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
ENOV broke above its upper Bollinger Band on August 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ENOV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.946) is normal, around the industry mean (10.725). P/E Ratio (0.000) is within average values for comparable stocks, (71.740). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.963). ENOV has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (0.605) is also within normal values, averaging (36.985).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ENOV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
